News
- Author:
- Bruce Jancin
Publish date: October 26, 2018
PARIS –The acne treatment adapalene 0.3%/benzoyl peroxide 2.5% gel prevented new scar formation in a multicenter study.
News
- Author:
- Bruce Jancin
Publish date: October 26, 2018
PARIS – Multiple phase 3 trials are underway for this promising agent.
News
- Author:
- Bruce Jancin
Publish date: October 25, 2018
CHICAGO – Largest-ever study answers two key patient management questions.
News
- Author:
- Bruce Jancin
Publish date: October 23, 2018
CHICAGO – The same MUC5B gene variant strongly associated with idiopathic pulmonary fibrosis is also a powerful r...
News
- Author:
- Bruce Jancin
Publish date: October 22, 2018
BARCELONA – Observed association between teen cannabis use and impaired inhibitory control called particularly troubling.
News
- Author:
- Bruce Jancin
Publish date: October 22, 2018
CHICAGO – Dominant B cell receptor clones predict imminent RA onset in high-risk individuals.
News
- Author:
- Bruce Jancin
Publish date: October 18, 2018
BARCELONA – Cross-sectional study of recently diagnosed young bipolar disorder patients breaks new ground.
News
- Author:
- Bruce Jancin
Publish date: October 17, 2018
BARCELONA – “The numbers are so shocking that you have to take it seriously.”
News
- Author:
- Bruce Jancin
Publish date: October 17, 2018
BARCELONA – An international expert names her top picks through the first three-quarters of 2018.
News
- Author:
- Bruce Jancin
Publish date: October 16, 2018
BARCELONA – “We now know that treating depression is about more than just getting the mood better,” Dr. Pratap Chokka said.
News
- Author:
- Bruce Jancin
Publish date: October 12, 2018
BARCELONA – The effects of a single 60-hour infusion lasted at least 30 days.
News
- Author:
- Bruce Jancin
Publish date: October 12, 2018
BARCELONA – A large Swedish national study found no hint of increased cancer risk in bipolar patients on lithium.
News
- Author:
- Bruce Jancin
Publish date: October 8, 2018
BARCELONA – “This is a compound with a very, very rich pharmacology – so rich that we don’t know exactly which of the pharmacologic effects are rea...
News
- Author:
- Bruce Jancin
Publish date: September 29, 2018
MUNICH – Large, national German TIM-HF2 trial also shows fewer hospitalizations than with usual care.
News
- Author:
- Bruce Jancin
Publish date: September 28, 2018
PARIS – Provocative findings from the unblinded, randomized Scottish trial contradict those of blinded ORBITA trial.
